Author: Bill Snyder
New clue to ADHD
May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.
Vision study changes how we see the brain
May. 10, 2012—Vanderbilt researchers have discovered that the pulvinar, a mysterious structure buried in the center of our brains, determines how we see the world — and whether we see at all.
Minds wide open: Neuroscience at Vanderbilt
Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.
Digestive disease research bolstered by grant renewal
Jan. 20, 2012—The Vanderbilt Digestive Disease Research Center celebrates its 10th anniversary this year with a second five-year renewal of its federal research grant.
Record number of VU faculty elected to AAAS
Dec. 22, 2011—Fourteen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. This is the largest number of Vanderbilt fellows to be elected in a single year on record. They are among 539 fellows from around the country selected by their peers because of their...
Initiative to help ‘translate’ diabetes research advances
Oct. 21, 2011—The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home.
Predicting hospital readmission is risky business: study
Oct. 18, 2011—Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.
Discoveries show value of federal support
Oct. 13, 2011—An update on federally funded projects at Vanderbilt and their impact on efforts to improve education, protect people from disease and meet our nation’s energy needs.
Researchers strive to refill drug discovery ‘pipeline’
Oct. 3, 2011—Researchers at Vanderbilt University Medical Center have made substantial progress in developing potential new treatments for Parkinson’s disease, schizophrenia and fragile X syndrome, the most common genetic form of autism.
Drug-like molecules aimed at improving treatment of Parkinson’s
Sep. 30, 2011—Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects.
VUMC to lead national consortium on biomedical research
Jul. 18, 2011—Vanderbilt University Medical Center has been awarded a five-year $20 million federal grant to coordinate a national consortium that aims to advance biomedical research nationwide.
VUMC awarded $20M to coordinate science consortium
Jun. 14, 2011—Consortium will advance biomedical research nationwide.
